Dana–Farber Cancer Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2022

  1. Curated variation benchmarks for challenging medically relevant autosomal genes

    Nature Biotechnology, Vol. 40, Núm. 5, pp. 672-680

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2017

  1. Association between telomere length and risk of cancer and non-neoplastic diseases a mendelian randomization study

    JAMA Oncology, Vol. 3, Núm. 5, pp. 636-651

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in invitro and invivo model of anaplastic thyroid carcinoma

    Molecular Oncology, Vol. 9, Núm. 1, pp. 78-92

2013

  1. Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells

    Endocrine-Related Cancer, Vol. 20, Núm. 5, pp. 633-647